SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 5)

VolitionRX Ltd

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

928661107

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

928661107

Names of Reporting Persons

Lagoda Investment Management, L.P.

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 17,070,103.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 17,070,103.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

17,070,103.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

10.7 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person: See Item 2 for additional information.

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

VolitionRX Ltd

(b)

Address of issuer's principal executive offices:

1489 West Warm Springs Road Suite 110 Henderson NV 89014

Item 2.

(a)

Name of person filing:

This report on Schedule 13G/A (as amended, this "Schedule 13G") is being filed by Lagoda Investment Management, L.P. (the "Reporting Person"). The Reporting Person serves as the investment manager to certain managed accounts(the "Accounts") and possesses the sole power to vote and the sole power to direct the disposition of all securities of the Issuer held by the Accounts. The general partner of the Reporting Person is Lagoda Investment Management, LLC, a Delaware limited liability company (the "General Partner"). Fatima Dickey, as the sole member of the General Partner, possesses the voting and dispositive power with respect to all securities beneficially owned by the Reporting Person. As of March 31, 2026, the Accounts held (i) 16,149,000 shares of common stock, par value $0.001 per share (the "Common Stock"), and (ii) warrants to purchase 921,103 shares of Common Stock at an exercise price of $0.60 per share. Based on information disclosed in the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission on March 31, 2026, there were 158,481,243 shares of Common Stock outstanding as of March 26, 2026. As a result of the foregoing, for purposes of Reg. Section 240.13d-3, the Reporting Person beneficially owns 17,070,103 shares of Common Stock, including shares of Common Stock underlying warrants held in the aggregate by the Accounts.

(b)

Address or principal business office or, if none, residence:

The address for the Reporting Person is 3 Columbus Circle, New York, NY 10019.

(c)

Citizenship:

The Reporting Person is organized under the laws of the State of Delaware.

(d)

Title of class of securities:

Common Stock, par value $0.001 per share

(e)

CUSIP No.:

928661107

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

17,070,103.00

(b)

Percent of class:

10.7 %

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

17,070,103.00

(ii) Shared power to vote or to direct the vote:

(iii) Sole power to dispose or to direct the disposition of:

17,070,103.00

(iv) Shared power to dispose or to direct the disposition of:

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lagoda Investment Management, L.P.

Signature:	/s/ Jason A. Ozone
Name/Title:	Chief Financial Officer & Chief Compliance Officer
Date:	05/15/2026

Amendment: SEC Form SCHEDULE 13G/A filed by VolitionRX Limited